Pharmaceuticals
-
Business
Eli Lilly’s LLY Stock Surges on Drug Tariff Boost and Trial Shifts
LLY stock rallies as Eli Lilly benefits from U.S. tariff protections, a favorable drug pricing outlook, and pipeline trial adjustments.
Read More » -
Business
Novo Nordisk Cuts Off Hims & Hers Over Wegovy Dispute, Putting a Spotlight on Telehealth’s Regulatory Edge
Novo Nordisk abruptly ended its partnership with Hims & Hers, citing the illegal distribution of compounded Wegovy alternatives. The fallout…
Read More »
